by BenevolentAI
BenevolentAI applies AI to AI-enabled drug discovery platform for target identification, biological reasoning, and therapeutic program development.
Web appContact for pricing
Step 1: Begin with a narrowly defined scientific or clinical-development question that matches BenevolentAI's purpose: AI-enabled drug discovery platform for target identification, biological reasoning, and therapeutic program development. Document the target, endpoint, assay, cohort, protocol, or decision criterion before running the AI workflow so the team can judge whether the output is actually useful.
Step 2: Use high-quality source data and keep provenance attached to every important result. For molecular or protein design, retain the model version, sequence or structure inputs, scoring criteria, and experimental follow-up. For clinical-data or trial workflows, preserve cohort definitions, inclusion and exclusion logic, source-record links, and investigator review.
Step 3: Evaluate prospective performance rather than only attractive retrospective examples. Track false positives, false negatives, failed experiments, uncertainty, and subgroup behavior. Do not promote a computational prediction into a biological fact, patient-level conclusion, or trial decision without the appropriate experimental or clinical validation.
Step 4: Before production or regulated use, review privacy, consent, data licensing, security, auditability, model validation, reproducibility, regional requirements, and human oversight. Pricing is currently classified as contact, but confirm current commercial terms with the provider.
Haystack EnrollHaystack Health is a clinical trial platform built for health plans and ACOs. It matches high-need members to industry-sponsored trials and provides care navigation through the process.
BEKhealthBEKhealth uses AI to read structured and unstructured EHR data for clinical trial feasibility, patient matching and real-world data. It serves sponsors, CROs, site networks and research sites.
Relation TherapeuticsRelation Therapeutics is a drug-discovery company that uses proprietary data and AI platforms to decide which biology to pursue. It develops medicines in bone, cardio-renal, dermatology and rheumatology.